VERIFYME INC (VRME)

US92346X2062 - Common Stock

1.6  +0.25 (+18.52%)

Premarket: 1.63 +0.03 (+1.87%)

Fundamental Rating

2

Taking everything into account, VRME scores 2 out of 10 in our fundamental rating. VRME was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. VRME has a bad profitability rating. Also its financial health evaluation is rather negative. VRME is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

VRME had negative earnings in the past year.
In the past year VRME had a positive cash flow from operations.
In the past 5 years VRME reported 4 times negative net income.
In the past 5 years VRME reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -22.40%, VRME is doing worse than 75.21% of the companies in the same industry.
VRME has a worse Return On Equity (-32.31%) than 74.38% of its industry peers.
Industry RankSector Rank
ROA -22.4%
ROE -32.31%
ROIC N/A
ROA(3y)-23.04%
ROA(5y)-80.68%
ROE(3y)-38.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of VRME (37.14%) is better than 63.64% of its industry peers.
VRME's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for VRME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.41%
GM growth 5Y-13.02%

3

2. Health

2.1 Basic Checks

VRME does not have a ROIC to compare to the WACC, probably because it is not profitable.
VRME has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VRME has been increased compared to 5 years ago.
The debt/assets ratio for VRME is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -4.34, we must say that VRME is in the distress zone and has some risk of bankruptcy.
VRME's Altman-Z score of -4.34 is on the low side compared to the rest of the industry. VRME is outperformed by 90.08% of its industry peers.
The Debt to FCF ratio of VRME is 3.10, which is a good value as it means it would take VRME, 3.10 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.10, VRME is in the better half of the industry, outperforming 66.94% of the companies in the same industry.
VRME has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
VRME has a Debt to Equity ratio (0.16) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 3.1
Altman-Z -4.34
ROIC/WACCN/A
WACC10.37%

2.3 Liquidity

A Current Ratio of 1.74 indicates that VRME should not have too much problems paying its short term obligations.
The Current ratio of VRME (1.74) is worse than 68.59% of its industry peers.
A Quick Ratio of 1.74 indicates that VRME should not have too much problems paying its short term obligations.
VRME has a Quick ratio of 1.74. This is comparable to the rest of the industry: VRME outperforms 52.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74

4

3. Growth

3.1 Past

VRME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.82%, which is quite good.
Looking at the last year, VRME shows a decrease in Revenue. The Revenue has decreased by -3.96% in the last year.
VRME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 224.82% yearly.
EPS 1Y (TTM)8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-155.56%
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y320.68%
Revenue growth 5Y224.82%
Sales Q2Q%-3.02%

3.2 Future

VRME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.09% yearly.
The Revenue is expected to grow by 2.42% on average over the next years.
EPS Next Y38.8%
EPS Next 2Y14.04%
EPS Next 3Y13.09%
EPS Next 5YN/A
Revenue Next Year-3.18%
Revenue Next 2Y0.82%
Revenue Next 3Y2.42%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

VRME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VRME. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, VRME is valued a bit cheaper than the industry average as 71.07% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.82
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as VRME's earnings are expected to grow with 13.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.04%
EPS Next 3Y13.09%

0

5. Dividend

5.1 Amount

No dividends for VRME!.
Industry RankSector Rank
Dividend Yield N/A

VERIFYME INC

NASDAQ:VRME (1/6/2025, 8:07:32 PM)

Premarket: 1.63 +0.03 (+1.87%)

1.6

+0.25 (+18.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners10.32%
Inst Owner Change0%
Ins Owners18.17%
Ins Owner Change1.56%
Market Cap16.80M
Analysts85
Price Target2.3 (43.75%)
Short Float %0.31%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.86%
Min EPS beat(2)-114.75%
Max EPS beat(2)69.04%
EPS beat(4)3
Avg EPS beat(4)26.32%
Min EPS beat(4)-114.75%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)22.09%
EPS beat(12)8
Avg EPS beat(12)-8.25%
EPS beat(16)11
Avg EPS beat(16)-7.09%
Revenue beat(2)1
Avg Revenue beat(2)-2.4%
Min Revenue beat(2)-6.65%
Max Revenue beat(2)1.84%
Revenue beat(4)1
Avg Revenue beat(4)-2.67%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)1.84%
Revenue beat(8)3
Avg Revenue beat(8)-1.1%
Revenue beat(12)4
Avg Revenue beat(12)-0.07%
Revenue beat(16)6
Avg Revenue beat(16)2.21%
PT rev (1m)0%
PT rev (3m)50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF 24.82
P/OCF 14.66
P/B 1.63
P/tB 21.85
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)0.06
FCFY4.03%
OCF(TTM)0.11
OCFY6.82%
SpS2.41
BVpS0.98
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.4%
ROE -32.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.14%
FCFM 2.68%
ROA(3y)-23.04%
ROA(5y)-80.68%
ROE(3y)-38.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.41%
GM growth 5Y-13.02%
F-Score7
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 3.1
Debt/EBITDA N/A
Cap/Depr 39.12%
Cap/Sales 1.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z -4.34
F-Score7
WACC10.37%
ROIC/WACCN/A
Cap/Depr(3y)106.86%
Cap/Depr(5y)170.78%
Cap/Sales(3y)11.45%
Cap/Sales(5y)23.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-155.56%
EPS Next Y38.8%
EPS Next 2Y14.04%
EPS Next 3Y13.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.96%
Revenue growth 3Y320.68%
Revenue growth 5Y224.82%
Sales Q2Q%-3.02%
Revenue Next Year-3.18%
Revenue Next 2Y0.82%
Revenue Next 3Y2.42%
Revenue Next 5YN/A
EBIT growth 1Y47.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year126.83%
EBIT Next 3Y34.67%
EBIT Next 5YN/A
FCF growth 1Y117.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y132.28%
OCF growth 3YN/A
OCF growth 5YN/A